07:00 , Mar 22, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Nerve damage Chondroitin sulfate proteoglycan (CSPG); chondroitin sulphate E (CS-E) In vitro and mouse studies suggest inhibiting the CSPG disaccharide subunit CS-E could help treat...